As CRY1 has been previously shown to undergo aberrant DNA methylation events in various human cancers [7], [22], we then examined whether epigenetic silencing could explain CRY1 mRNA expression differences in CLL. The gene discussed is CRY1; the disease is B-cell chronic lymphocytic leukemia.